VANGUARD GROUP INC 13D and 13G filings for Puma Biotechnology, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-13 5:12 pm Purchase | 2023-12-29 | 13G | Puma Biotechnology, Inc. PBYI | VANGUARD GROUP INC | 3,802,081 7.990% | 213,159 (+5.94%) | Filing |
| 2023-02-09 11:30 am Sale | 2022-12-30 | 13G | Puma Biotechnology, Inc. PBYI | VANGUARD GROUP INC | 3,588,922 7.860% | -91,265 (-2.48%) | Filing |
| 2022-02-10 08:32 am Purchase | 2021-12-31 | 13G | Puma Biotechnology, Inc. PBYI | VANGUARD GROUP INC | 3,680,187 9.000% | 283,498 (+8.35%) | Filing |
| 2021-02-10 11:40 am Sale | 2020-12-31 | 13G | Puma Biotechnology, Inc. PBYI | VANGUARD GROUP INC | 3,396,689 8.540% | -589,437 (-14.79%) | Filing |